BE901095A - Nouvelles compositions anthelminthiques et leur preparation. - Google Patents
Nouvelles compositions anthelminthiques et leur preparation.Info
- Publication number
- BE901095A BE901095A BE0/214033A BE214033A BE901095A BE 901095 A BE901095 A BE 901095A BE 0/214033 A BE0/214033 A BE 0/214033A BE 214033 A BE214033 A BE 214033A BE 901095 A BE901095 A BE 901095A
- Authority
- BE
- Belgium
- Prior art keywords
- novel
- preparation
- anthelminthic compositions
- anthelminthic
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000000507 anthelmentic effect Effects 0.000 title abstract 2
- SGKGVABHDAQAJO-UHFFFAOYSA-N nitroxynil Chemical class OC1=C(I)C=C(C#N)C=C1[N+]([O-])=O SGKGVABHDAQAJO-UHFFFAOYSA-N 0.000 abstract 2
- MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 abstract 1
- CTPDSKVQLSDPLC-UHFFFAOYSA-N 2-(oxolan-2-ylmethoxy)ethanol Chemical compound OCCOCC1CCCO1 CTPDSKVQLSDPLC-UHFFFAOYSA-N 0.000 abstract 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 abstract 1
- 229960001614 levamisole Drugs 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Une composition pharmaceutique qui comprend le sel de nitroxynil de lévamisole en solution dans un solvant comprenant du diméthylisosorbide, du glycofurol ou un mélange des deux et contenant jusqu'à 40 % (poids/volume) de sel de nitroxynil de lévamisole. Cette composition possède des propriétés anthelminthiques et est utilisée dans la lutte contre l'helminthiose. Par ailleurs, elle se présente sous la forme d'un dosage unitaire et est destinée à une administration parentérale.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838331037A GB8331037D0 (en) | 1983-11-21 | 1983-11-21 | Compositions of matter |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE901095A true BE901095A (fr) | 1985-05-20 |
Family
ID=10552109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/214033A BE901095A (fr) | 1983-11-21 | 1984-11-20 | Nouvelles compositions anthelminthiques et leur preparation. |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS60123419A (fr) |
| AU (1) | AU3564984A (fr) |
| BE (1) | BE901095A (fr) |
| CA (1) | CA1236402A (fr) |
| CH (1) | CH662273A5 (fr) |
| DE (1) | DE3442402A1 (fr) |
| DK (1) | DK548884A (fr) |
| ES (1) | ES8600933A1 (fr) |
| FR (1) | FR2555047B1 (fr) |
| GB (2) | GB8331037D0 (fr) |
| HU (1) | HU196307B (fr) |
| IT (1) | IT1177262B (fr) |
| NL (1) | NL8403528A (fr) |
| NZ (1) | NZ210247A (fr) |
| ZA (1) | ZA849008B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0147883A3 (fr) * | 1983-12-21 | 1986-12-30 | Janssen Pharmaceutica N.V. | Formulations "pour-on" anthelmintiques aqueuses et non-aggressives |
| AU5733986A (en) * | 1985-05-13 | 1986-11-20 | Syntex (U.S.A.) Inc. | Anthelmintic compositions comprising a benzimidazole derivative and the fasciolicide rafoxanide |
| IT1223343B (it) * | 1987-11-03 | 1990-09-19 | Also Lab Sas | Formulazioni farmaceutiche per somministrazione transdermica |
| BRPI0506279B1 (pt) | 2005-12-16 | 2018-01-09 | Npa - Núcleo De Pesquisas Aplicadas Ltda | Composição sinergística de antihelmínticos e endectocidas |
| CN100500648C (zh) * | 2006-12-29 | 2009-06-17 | 浙江工业大学 | 一种硝碘酚腈的合成方法 |
| BRPI0904365A2 (pt) * | 2009-11-05 | 2011-11-16 | Ouro Fino Participacoes E Empreendimentos S A | associações farmacêuticas, composições farmacêuticas, medicamento e método para o tratamento de animais |
| WO2012089623A1 (fr) * | 2010-12-27 | 2012-07-05 | Intervet International B.V. | Formulation d'isoxazoline d'application topique locale comprenant du glycofurol |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4082881A (en) * | 1976-12-23 | 1978-04-04 | E. R. Squibb & Sons, Inc. | Topical and other type pharmaceutical formulations containing isosorbide carrier |
| AU527154B2 (en) * | 1978-12-15 | 1983-02-17 | Pitman-Moore Australia Limited | Composition and process |
| EP0052962B1 (fr) * | 1980-11-20 | 1984-05-09 | Beecham Group Plc | Compositions pharmaceutiques contenant deux dérivés de bêta-lactame |
| NZ202422A (en) * | 1981-11-25 | 1985-02-28 | Ici Australia Ltd | D, l-and l-2,3,5,6-tetrahydro-6-phenylimidazo(2,1-b)thiazolium 4-cyano-2-iodo-6-nitrophenoxide and veterinary compositions |
-
1983
- 1983-11-21 GB GB838331037A patent/GB8331037D0/en active Pending
-
1984
- 1984-11-19 NZ NZ210247A patent/NZ210247A/en unknown
- 1984-11-19 DK DK548884A patent/DK548884A/da not_active Application Discontinuation
- 1984-11-19 ZA ZA849008A patent/ZA849008B/xx unknown
- 1984-11-19 AU AU35649/84A patent/AU3564984A/en not_active Abandoned
- 1984-11-19 JP JP59242550A patent/JPS60123419A/ja active Pending
- 1984-11-20 BE BE0/214033A patent/BE901095A/fr not_active IP Right Cessation
- 1984-11-20 CA CA000468249A patent/CA1236402A/fr not_active Expired
- 1984-11-20 DE DE19843442402 patent/DE3442402A1/de not_active Withdrawn
- 1984-11-20 HU HU844307A patent/HU196307B/hu unknown
- 1984-11-20 NL NL8403528A patent/NL8403528A/nl not_active Application Discontinuation
- 1984-11-20 FR FR8417647A patent/FR2555047B1/fr not_active Expired
- 1984-11-20 GB GB08429264A patent/GB2150024B/en not_active Expired
- 1984-11-20 IT IT23660/84A patent/IT1177262B/it active
- 1984-11-21 CH CH5562/84A patent/CH662273A5/fr not_active IP Right Cessation
- 1984-11-21 ES ES537825A patent/ES8600933A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2555047B1 (fr) | 1987-04-17 |
| DK548884D0 (da) | 1984-11-19 |
| AU3564984A (en) | 1985-05-30 |
| DK548884A (da) | 1985-05-22 |
| DE3442402A1 (de) | 1985-05-30 |
| ES537825A0 (es) | 1985-10-16 |
| ES8600933A1 (es) | 1985-10-16 |
| IT8423660A0 (it) | 1984-11-20 |
| GB2150024A (en) | 1985-06-26 |
| CA1236402A (fr) | 1988-05-10 |
| HUT35955A (en) | 1985-08-28 |
| JPS60123419A (ja) | 1985-07-02 |
| GB2150024B (en) | 1987-02-04 |
| NZ210247A (en) | 1988-01-08 |
| CH662273A5 (fr) | 1987-09-30 |
| GB8331037D0 (en) | 1983-12-29 |
| GB8429264D0 (en) | 1984-12-27 |
| FR2555047A1 (fr) | 1985-05-24 |
| NL8403528A (nl) | 1985-06-17 |
| ZA849008B (en) | 1985-07-31 |
| IT8423660A1 (it) | 1986-05-20 |
| HU196307B (en) | 1988-11-28 |
| IT1177262B (it) | 1987-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Veber et al. | A super active cyclic hexapeptide analog of somatostatin | |
| IL71326A (en) | Corticotropin releasing factor analogs and pharmaceutical compositions containing them | |
| EP0327756B1 (fr) | Compositions pharmaceutiques contenant une calcitonine et un glycyrrhizinate comme promoteur d'absoption | |
| EP0221041A3 (fr) | Dérivés de benzimidazole, leur préparation et leur application comme médicaments | |
| DE3065420D1 (en) | Pharmaceutical composition containing sanguinaria and galangal suitable for treatment of periodentitis and tumours | |
| TNSN03085A1 (fr) | Composition parenterale reconstituable contenant un inhibiteur de cox-2 | |
| IL93119A0 (en) | Purified intracellular adhesion molecule-1,dna encoding it,its preparation and pharmaceutical compositions containing it | |
| BE904233A (fr) | Peptides et derives peptidiques, leur preparation, leur utilisation en therapeutique et compositions pharmaceutiques les contenant. | |
| BE901095A (fr) | Nouvelles compositions anthelminthiques et leur preparation. | |
| BE904796A (fr) | Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant. | |
| US5491171A (en) | Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration | |
| EP0173664A3 (fr) | Dérivés de benzimidazole biologiquement actifs et leur procédé de préparation | |
| CA2318326A1 (fr) | Nouveaux pentasaccharides, procedes de preparation et compositions pharmaceutiques ainsi constituees | |
| KR920008060A (ko) | 약제적 활성물질을 제피 또는 봉매하기 위한 갈락토만난 유도체 | |
| FR2368959A1 (fr) | Compositions contenant des derives de l'acide guanidinoalcanoique, utilisables comme medicament | |
| Shimkin et al. | Trisethylene-imino-s-triazine (triethylene melamine or TEM) in the treatment of neoplastic diseases | |
| US3657436A (en) | Method of treating col-sk virus infections | |
| PT84943B (pt) | Processo para a preparacao de composicoes farmaceuticas contendo uma mistura de pelo menos, um polipeptido, um monossacarido e um polioxialquileno-eter | |
| EP0500586A1 (fr) | Inhibiteurs de biosynthese de pyrimidine utiles en tant qu'agents immunosuppresseurs | |
| JP3535207B2 (ja) | 抗ガン剤及びｇｒｐレセプター拮抗剤 | |
| IE44117B1 (en) | Pharmaceutical compositions having diuretic and antihypertensive activity | |
| CA2167841A1 (fr) | Methode d'inhibition de la production de virus d'immunodeficience humaine a l'aide de derives de substitution d'azaspiranes | |
| US3502774A (en) | Anthelmintic method using 6-methoxy-1-phenazinol 5,10-dioxide | |
| KR19990087206A (ko) | 항종양제 함유 조성물 | |
| GB1573730A (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: MAY & BAKER LTD Effective date: 19891130 |